HHS sponsors development of drug to treat infections from biowarfare agents, antibiotic-resistant bacteria
The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services, will sponsor the next stages of development of an antibiotic that not only holds potential as a treatment for infections from certain types of drug-resistant bacteria but also may be able to combat infections caused by bacteria used in biowarfare.
Product development may address aspect of national preparedness against nuclear threats
HHS, Regeneron partner on portfolio of treatments for pandemic influenza, emerging infectious diseases
The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and Regeneron Pharmaceuticals, Inc. of Tarrytown, New York, will forge a public-private partnership to drive development of an entire portfolio of products to treat influenza and other emerging infectious diseases...